Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Daniel S. Strasser"'
Autor:
Peter Blattmann, Hervé Farine, Brian Dan, Nicole Stiffler, Thomas Lefebvre, Christine Huynh, Patricia N. Sidharta, Jasper Dingemanse, Richard W. D. Welford, Marcel Keller, Daniel S. Strasser
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 2, Pp n/a-n/a (2024)
Abstract CXCL12 acts as a chemoattractant by binding to the receptor CXCR4. The (atypical) chemokine receptor ACKR3 (CXCR7) scavenges CXCL12. Antagonism of ACKR3 thus leads to an increase in CXCL12 concentrations that has been used as a pharmacodynam
Externí odkaz:
https://doaj.org/article/e53b8c21584147f092daf12cfbcb0485
Autor:
Richard W.D. Welford, Herve Farine, Michel Steiner, Marco Garzotti, Kostantin Dobrenis, Claudia Sievers, Daniel S. Strasser, Yasmina Amraoui, Peter M.A. Groenen, Roberto Giugliani, Eugen Mengel
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 30, Iss , Pp 100843- (2022)
GM2 and GM1 gangliosidoses are genetic, neurodegenerative lysosomal sphingolipid storage disorders. The earlier the age of onset, the more severe the clinical presentation and progression, with infantile, juvenile and late-onset presentations broadly
Externí odkaz:
https://doaj.org/article/2598cb3f1138405aab2f37467293894f
Autor:
Laetitia Pouzol, Anna Sassi, Nadège Baumlin, Mélanie Tunis, Daniel S. Strasser, François Lehembre, Marianne M. Martinic
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Loss of control in the trafficking of immune cells to the inflamed lung tissue contributes to the pathogenesis of life-threatening acute lung injury (ALI) and its more severe form, acute respiratory distress syndrome (ARDS). Targeting CXCR7 has been
Externí odkaz:
https://doaj.org/article/87143f960dcd406b842cdbeee31d0c1a
Autor:
Emmanuel A. Meyer, Päivi Äänismaa, Eric A. Ertel, Eva Hühn, Daniel S. Strasser, Markus Rey, Mark J. Murphy, Marianne M. Martinic, Laetitia Pouzol, Sylvie Froidevaux, Marcel P. Keller, Eva Caroff
Publikováno v:
Journal of Medicinal Chemistry. 66:4179-4196
Publikováno v:
Journal of Family Communication. 22:55-70
Autor:
Mohamed Al-Ibrahim, Christine Huynh, Mike Ufer, Daniel S. Strasser, Andrea Henrich, Henriette E. Meyer zu Schwabedissen, Marie-Laure Boof, Jasper Dingemanse
Publikováno v:
Clinical Pharmacology & Therapeutics. 109:1648-1659
The C-X-C chemokine receptor 7 (CXCR7) has evolved as a promising, druggable target mainly in the immunology and oncology fields modulating plasma concentrations of its ligands CXCL11 and CXCL12 through receptor-mediated internalization. This "scaven
Publikováno v:
Communication Quarterly. 69:1-22
Communication Privacy Management theory (CPM) was applied in a qualitative analysis of survey responses from parents in transracial, internationally adoptive families concerning their management of...
Autor:
Daniel S. Strasser
Publikováno v:
Inside Relationships ISBN: 9781003025023
Inside Relationships
Inside Relationships
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::610db73be90a23e5755f26d0508c60dc
https://doi.org/10.4324/9781003025023-14
https://doi.org/10.4324/9781003025023-14
Autor:
Mélanie Tunis, Anna Sassi, Nadège Baumlin, Daniel S. Strasser, François Lehembre, Laetitia Pouzol, Marianne M Martinic
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, Vol 12 (2021)
Loss of control in the trafficking of immune cells to the inflamed lung tissue contributes to the pathogenesis of life-threatening acute lung injury (ALI) and its more severe form, acute respiratory distress syndrome (ARDS). Targeting CXCR7 has been
Autor:
Ulrich Mentzel, Markus Kramberg, Marc Iglarz, Enrico Vezzali, Frederic Trensz, Céline Bortolamiol, Daniel Wanner, Stephane Delahaye, Hakim Hadana, Daniel S. Strasser, Patrick Hess, Markus Rey, Joël Ménard, Martine Clozel
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 368:462-473
The endothelin (ET) system has emerged as a novel target for hypertension treatment where a medical need persists despite availability of several pharmacological classes, including renin angiotensin system (RAS) blockers. ET receptor antagonism has d